Mitsubishi Tanabe Pharma Europe Ltd - Company Review
Mitsubishi Tanabe Pharma Europe Ltd - Company ReviewSummary
Mitsubishi Tanabe Pharma Europe Ltd (MTPE), formerly Mitsubishi Pharma Europe Ltd, a subsidiary of Mitsubishi Tanabe Pharma Corp is a drug company that conducts clinical research and commercial operations. The company manufactures argatroban for anticoagulation in adult patients with heparin-induced thrombocytopenia Type I. It also holds authorization for marketing drugs such as exembol, argatra, arganova, novastan, and bindren. MTPE conducts clinical research to discover new medicines for patients. The company offers its products for different diseases, which include multiple sclerosis, psoriasis, and diabetic nephropathy. It markets its product through its network of distributors across the world. The company has its presence in the UK and Germany. MTPE is headquartered in London, the UK.
This comprehensive company report of Mitsubishi Tanabe Pharma Europe Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.